EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Basophil Activation Testing: From Diagnostic Adjunct to Precision Allergy Management

Francesco Catamerò, Jooeun Han, Deniz Eyice Karabacak, Hans Jürgen Hoffmann, Bernhard F. Gibbs, Edward Knol, Cristobalina Mayorga, Maria Josè Torres, Anna Nopp, Mattia Giovannini, Francesca Mori, Alexandra F. Santos and 4 more

Allergy · 2026-11-22

DOI: 10.1111/all.70573 ↗

At a glance

Journal article in Allergy, published online on 2026-11-22. Written by Francesco Catamerò and 15 co-authors. 178 references. The full text is freely available (open access, CC BY 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Basophils are rare circulating granulocytes that trigger immediate hypersensitivity reactions through IgE‐mediated degranulation and also contribute to innate immunity. The basophil activation test (BAT) is a flow cytometry‐based functional assay that quantifies basophil reactivity and sensitivity following allergen stimulation, offering a safe, blood‐based alternative to in vivo provocation testing. This review summarizes the immunological basis of the BAT, its technical requirements, and its expanding clinical applications across food, respiratory, drug, and hymenoptera venom allergies, autoimmune chronic spontaneous urticaria, and vaccine hypersensitivity. Beyond diagnosis, the BAT increasingly supports monitoring of allergen immunotherapy and biologic treatments, prediction of reaction severity and treatment response, and personalized management decisions. Its performance varies by allergen and clinical context, and wider adoption is constrained by the absence of standardized protocols, validated cut‐offs, and reference materials, as well as by basophil non‐releasers and dependence on fresh viable blood. Passive BAT and mast cell activation test formats extend testing to patients in whom the conventional BAT is uninterpretable. Automated, data‐driven analysis and machine learning‐assisted, label‐free platforms offer promising routes toward more objective, scalable interpretation. With continued standardization, harmonization, and prospective validation, the BAT is positioned not only as a diagnostic adjunct but as a platform for precision‐based allergy management.

Cite

APA

Catamerò, F., Han, J., Karabacak, D. E., Hoffmann, H. J., Gibbs, B. F., Knol, E., Mayorga, C., Torres, M. J., Nopp, A., Giovannini, M., Mori, F., Santos, A. F., Durham, S., Akdis, C. A., Layhadi, J. A., & Shamji, M. H. (2026). Basophil Activation Testing: From Diagnostic Adjunct to Precision Allergy Management. Allergy. https://doi.org/10.1111/all.70573

Vancouver

Catamerò F, Han J, Karabacak DE, Hoffmann HJ, Gibbs BF, Knol E, et al. Basophil Activation Testing: From Diagnostic Adjunct to Precision Allergy Management. Allergy. 2026. doi:10.1111/all.70573

BibTeX
@article{Catamer2026,
  author = {Catamerò, Francesco and Han, Jooeun and Karabacak, Deniz Eyice and Hoffmann, Hans Jürgen and Gibbs, Bernhard F. and Knol, Edward and Mayorga, Cristobalina and Torres, Maria Josè and Nopp, Anna and Giovannini, Mattia and Mori, Francesca and Santos, Alexandra F. and Durham, Stephen and Akdis, Cezmi A. and Layhadi, Janice A. and Shamji, Mohamed H.},
  title = {Basophil Activation Testing: From Diagnostic Adjunct to Precision Allergy Management},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70573}
}
Start for free →